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Abstract 
Calcium phosphate ceramics are used in bone sur-
gery under different forms: dense or porous ceramics as 
bone substitute, thin ceramic coatings on metallic im-
plants as an osseointegration enhancer. Their degrada-
tion depends on their physico-chemical properties and 
particularly on their chemical composition. Natural cal-
cium phosphates of bone are degraded by mononuclear 
or multinuclear cells and the extracellular matrix induces 
the differentiation of the degrading-cells. Hydroxyapa-
tite, which is one of the most used calcium phosphates , 
is known as a low degradation material. However , the 
histological analysis of implanted HA-materials both in 
animals and in humans showed that a cellular degrada-
tion took place on the surface of the material. 
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Introduction 
Hydroxyapatite (HA) ceramics are used daily in 
human and an imal surgery under different forms [31. 
36]. This material is classified as a surface-active bio-
material [33]. It means that an interfacial bond is 
formed between the material and the tissue in which it is 
implanted . Calcium phosphate materials , currently used 
in human surgery , are assumed by surgeons to be non -
or slowly degradable materials. Depending on its use , 
a degradation may be necessary to improve osseointe-
gration [20]. 
HA-materials such as HA-coatings and macropo-
rous-HA can be considered to have a chemical composi -
tion which is close to bone mineral [ 42]. All other char-
acteristics are radically different. The macroporous 
ceramic can be composed of a single calcium phosphate 
phase . HA-coatings can contain other calcium phosphate 
phases in their amorphous phase [61]. The size of the 
crystallites of bone is much smaller than the size of 
ceramic grains , and the structure and the texture of bone 
and ceramics are totally different [51]. Despite these 
differences , based on its close chemical composition to 
that of the bone mineral , HA is assumed to be a bio-
degradable material. 
The purpose of this article is to discuss some 
observations made on HA ceramic degradation in a 
biological environment. 
Calcium phosphate ceramics 
Ceramic material can be defined as all solid mate-
rials which are neither metal nor organic. Ceramics are 
heterogeneous material constituted by grains which are 
assembled using a thermal process (sintering stage). 
They can be used in the form of bulk or porous material 
obtained by slip casting or machining. Moreover , thin 
coatings of calcium phosphate ceramic on metal alloys , 
polymers and composites can be obtained by plasma-
spraying of HA-powder. The characteristics of the ce-
ramic will have a great influence on the resorption of the 
material. Moreover , different calcium phosphates can 
be used to manufacture bioceramics. The HA and the 
,B-tricalcium phosphate (,B-TCP) are the most commonly 
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Figure 1. X-ray diffraction patterns of: HA-powder before plasma-spraying (A) , and of the obtained HA-coating (B). 
The peaks are broader after the plasma-spraying indicating the presence of an amorphous phase after the spray. 
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Figure 2. Scanning electron micrograph of an HA ce-
ramic surface showing the grains constituting the ceram-
ic . Small holes exist between the grains (arrowheads) ; 
they are randomly distributed and not interconnected , 
constituting the microporosity of the ceramic . Bar = 
50 ,urn . 
on the solubility required for the material. HA is con-
sidered to be quite insoluble and {3 -TCP soluble when 
tested in vitro . 
Different phases can appear in the HA-ceramics 
according to the sintering protocol adopted and the puri -
ty of the powder used to manufacture the ceramic. 
{3 -tricalcium phosphate ({3 -TCP) can appear during the 
manufacturing process of HA-ceramics. An amorphous 
phase , which has a Ca/P ratio identical to the Ca/P ratio 
of HA but which cannot be identified as HA by X-ray 
diffraction , can also be found in HA-ceramic coatings . 
These phases do not have the same solubility as pure 
crystalline HA. The crystallinity of the ceramic is meas-
ured by X-ray diffraction (XRD) . The broadening of the 
XRD pattern peaks after plasma-spraying is representa-
tive of the amount of amorphous phase in the ceramic. 
Amorphous phase which can contain other calcium phos-
phate phases , such as {3-TCP or calcium oxide , is more 
soluble than the crystalline phase [61] (Fig. 1). 
The porosity of the material is often divided into 
microporosity and macroporosity . The microporosity is 
due to the small spaces existing between the grains of 
the ceramic which were left by the shrinkage occurring 
during the material diffusion process at the grain bound-
aries (Fig . 2) . They have a diameter of less than a few 
micrometers and are not interconnected . The macropo-
rosity results from the shaping of the ceramic done in 
order to obtain a bone tissue ingrowth inside the ceram-
ic . The macropores should be interconnected and have 
a diameter of from 100 ,urn up to several millimeters. 
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The porosity of the material determines the size of the 
surface which is in contact with the body fluid. The sur-
face in contact with the tissue depends also on the inter-
connection of the material pores . It is generally admit-
ted that a pore diameter of more than 100 ,u m is neces-
sary for bone ingrowth [30] depending on the volume of 
the implanted ceramic. If the interconnection of the 
pores is poor , the size of the exposed surface will be 
smaller than if the pore connection is high. 
The size and the shape of the grains obtained after 
the sintering stage or plasma-spraying can vary and have 
an influence on the amount of the surface of the crystal-
line phase exposed to the body fluids . 
Degradation of bone calcium phosphate 
Bone mineral of the adult is composed of an A 
and AB carbonated non -stoichiometric apatite [ 42] . Nu -
cleation of carbonated apatite crystals within the bone 
extracellular matrix can be due to the removal of biolog-
ical inhibitors , to interaction between Ca2+ and calci-
um-binding proteins , or to apatite precipitation out of lo-
cally supersaturated calcium phosphate solution made by 
body fluids inside some microdomains [4 , 27 , 45 , 58]. 
Bone mineral crystals are first formed either inside "the 
holes" existing between the fibrils in the collagen bundle 
or inside extracellular matrix vesicles synthesized by os-
teoblasts. The bone mineral nucleation taking place in -
side these organic compartments is an heterogeneous 
secondary nucleation controlled by the molecules con-
tained inside these compartments. Subsequently , the 
mineralization spreads out of the nucleation site through-
out the extracellular matrix , this , making the bone an 
organa-mineral composite. 
A high degradation rate of the organa-mineral 
composite constituting the bone tissue by bone cells is 
already known in several pathological and physiological 
processes. Osteoclasts [12 , 44] are known to resorb 
bone tissue during remodelling phenomena which occur 
during the life of the bone. Bone tissue is resorbed by 
osteoclasts or giant cells , during Paget ' s disease . Some 
forms of osteoporosis , idiopathic osteolysis , and hyper-
parathyroidism are also characterized by the presence of 
many osteoclasts resorbing bone tissue. From the histo-
logical studies carried out in these pathologies, two dis-
tinct kinds of cells were shown to degrade bone tissue 
and calcium phosphate mineral: osteoclasts and mononu-
clear cells [ 13]. Histological analysis of bone allograft 
shows , in the same resorption sites , mononuclear cells, 
giant cells, and osteoclasts. 
Osteoclasts: Osteoclasts are multinucleated (2 to 
50 nuclei) giant cells (20 to 100 ,urn). Once in contact 
with the bone , the newly formed osteoclast begins to 
erode a cavity of characteristic shape and dimension . 
They have a central ruffled border with many cytoplas-
mic folds , surrounded by a clear zone where the cell is 
closely attached to the bone surface , forming a tempo-
rary seal around the site of bone destruction [17]. Cell 
attachment could be mediated by oligosaccharides [ 48] . 
The chemical processes mediating bone resorption are 
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numerous and complex. Dissolution of the mineral is 
the main task of the osteoclast which produces biochemi-
cal changes that includes release of acid, particularly 
lactic acid and citric acid [ 43], coupled with increased 
synthesis and release of lysosomal enzymes and other 
proteases [32]. Carbonic anhydrase, which hydrolyses 
carbonate into proton and carbon dioxide, plays a role in 
the acidification of the medium at the interface of bone 
and osteoclasts. The ruffled border membrane contains 
a protein identical to H+ -pump found in the lysosomal 
membrane [7]. The decrease of the pH induced by the 
proton-pump in the extracellular compartment facing the 
ruffled border seems to be responsible for the bone min-
eral degradation. Lysosomal enzymes secreted in this 
compartment could help to degrade the organic matrix. 
Furthermore, collagen fibrils could be degraded by other 
cells containing large amounts of collagenase such as os-
teoblasts [32] although osteoclasts could resorb the or-
ganic and inorganic components of bone as reported by 
Blair er al. [9]. However , the digestion of the collagen 
coating, existing on bone surface , by osteoblasts and lin-
ing cells could be necessary for osteoclast digestion of 
bone [15]. Complement (C3) adsorption on the exposed 
mineralized bone surfaces could mediate the recruitment 
of mononuclear preosteoclasts to this site [ 46]. Osteo-
clasts have been known for a long time to be involved in 
relation with osteoblasts in the normal remodelling of 
bone tissue. Osteoclast precursors may respond to spe-
cific humoral signals emanating from other bone cells 
such as active osteob1asts , lining cells , or immune cells 
synthesizing interleukin I a and {3 , tumoral necrosis 
factor a and {3, and transforming growth factors a and 
/3 [5 , 55]. 
Osteoclasts originate from hemopoietic tissue. 
They derive from mononuclear phagocytes as precur-
sors. They arise from a derivative of the hemopoietic 
stem cell that can become committed specifically to os-
teoclast generation [ 14] . The separation between osteo-
clasts and macrophages or giant cells lineage could come 
early [11]. Alternatively , it remains possible that osteo-
clasts could develop from mature mononuclear phagocyte 
by induction of osteoclastic differentiation in the special 
microenvironment of bone surface. Osteoclast pheno-
type has been well characterized and shown to express 
many of the antigens of the monocyte-macrophage line-
age [5]. Mononuclear cells identified in histological 
sections of bone , applied to the bone surface , show a 
similar immunophenotype to that of the multinucleated 
osteoclasts [6] . 
Marrow-derived giant cells express osteoclast-spe-
cific cell surface antigens when cultured with calvariae. 
In the mesenchymal cell containing chorioallantoic mem-
brane, intact bone matrix induced the formation of giant 
cells that express osteoclast-specific antigens [54]. De-
mineralized matrix and matrix components such as type 
I collagen, osteocalcin , osteopontin, osteonectin, bone-
derived growth factors, cartilage proteoglycan , hyal-
uronic acid , laminin, and fibronectin do not induce the 
formation of giant cells expressing osteoclast markers 
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(antigen 121 F) on their membrane [54]. In the same 
experiment, a culture medium, conditioned by chick 
hatched calvariae , induced the formation of giant cells 
having osteoclast markers from the culture of a mono-
cyte or marrow mononuclear cell population. It showed 
that the terminal stages of osteoclast differenti ation were 
influenced by soluble factors found in the bone environ-
ment. Glowacki et al. [28] showed that osteocalcin-defi-
cient bone particles were not associated with osteoclasts 
when implanted subcutaneously in rats. However, in the 
same experiment, it was shown that synthetic microcrys-
talline HA recruited multinucleated cells lacking the 
osteoclastic features [28]. 
Thus , osteoclast recruitment at the bone contact 
depends on specific or non-specific humoral signals and 
factors emanating from bone extra cellul ar matrix 
(ECM). However, ECM calcium phosphate materials 
can have an influence on osteoclast recruitment mediated 
by non-specific humoral signals such as C3 adsorption on 
the naked calcium phosphate surface. 
Other cells: It is not clear whether macrophages 
contribute directly to bone remodelling in v ivo . Evi-
dence has been presented that cells of the mononuclear 
phagocytic system are capable of bone resorption in var-
ious culture system. Cells of the mononuclear phago-
cytic system were shown to resorb implanted isogeneic 
bone matrix on ani mal. These cells are also present at 
the point of contact of bone tissue allograft in humans. 
Mononuclear cells could be responsible for the digestion 
of the bone collagen [32] and a part of the erosion cavity 
dug by the osteoclast [21]. It is unclear if these cells are 
precursor cells having failed to fuse or resorbing mono-
cytes [52] helping osteoclasts by the release of cyto-
kines. 
Furthermore, macrophages are interrelated with 
osteoblasts and synthesize cytokines which are able to 
regulate their activity [34, 56] . 
Degradation of ectopic natural HA-crystals 
Ectopic calcium phosphate crystals found in soft 
tissues induce a cellular response involving phagocytic 
cells . Calcium oxalate and dicalcium pyrophosphate de-
posits in soft tissues are surrounded by histiocytes and 
giant cells [10] . HA-crystals, identical to the HA-crys-
tals found in the human joint disease, having a diameter 
of between 0.1 and 5 ~-tm, induce prostaglandin E2 re-
lease by macrophages [2]. Apatite-containing particles 
are frequently found in osteoarthritic joints. Hydroxy-
apatite has been reported to induce acute inflammatory 
reaction in human skin [ 18] and synovitis after injection 
into dog's knee joints [60]. Articular chondrocytes were 
shown to secrete collagenase, protease , and prosta-
glandins E2 and F2 after phagocytosis of HA-particles. 
Cheung et al. [16] showed that the phagocytosis 
of HA-crystal found in osteoarthritic joint induced the 
multiplication of synovial cells. These results were 
attributed to the increase of cytoplasmic Ca2 + suggested 
by a degradation of the crystals once phagocytosed. 
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Degradation of hydroxyapatite-ceramics 
Chemical, biochemical and biological evidence 
of Hydroxyapatite-solubility: Hydroxyapatite is one of 
the less soluble calcium-phosphates used as bone substi-
tute materiaL The solubility phase diagram of the most 
frequently used calcium phosphates as biomaterials 
shows that although HA is the most stable phase under 
many conditions, it becomes less stable than dicalcium 
phosphate dihydrate (DCPD) if the solution is sufficient-
ly acidic. Such ranges of acid pH are commonly found 
in some cell compartments and particularly in cells re-
sponsible for the bone degradation. It is considered that 
both the endocytic and exocytic vacuolar apparatus in 
cells are maintained at low pH [3]. Endocytic vesicles , 
lysosomes, portions of the trans-Golgi apparatus, certain 
acid-producing secretory vesicles, and the "resorption 
chamber" of the osteoclast are low pH cell compart-
ments. Using fluorescein -labelled dextran , pH values of 
4. 7-4.8 were measured in macrophage lysosomes [57] . 
Similar pH values were measured by Baron et al. [7] in 
the extracellular resorption region of osteoclasts. A re-
cent report showed that cultured fibroblasts phago-
cytosed HA-particles inside or in close proximity to their 
acidic intracellular compartment identified by neutral red 
uptake [24]. Alliot-Licht et al. [1], Kwong et al. [41], 
and Orly et al. [53] have demonstrated that calcium 
phosphate grains having a size less than 50 JLm can be 
phagocytosed by several kinds of cells such as fibro-
blasts, osteoblasts, established osteoblast-like cell lines , 
synovial cells, and macrophages then degraded in intra-
cellular vesicles. Subsequent to the internalization of 
HA-particles , it has been observed that the growth rate 
and DNA synthesis of osteoblast were significantly in-
hibited [1]. The HA-particle size was found by Evans 
[22] to have an effect on the cytotoxicity of HA in vitro. 
Finely ground powders of HA reduced the growth rate of 
fibroblast line. The effect was dose-related and only oc-
curred with small particles (3-7 JLm). A physical effect 
could interfere with the cell growth. In particular, the 
elevated surface at the point of contact of the cell culture 
medium , when the ceramic powder was finely ground , 
could induce an ionic modification of the culture medium 
responsible for the cytotoxicity of the ceramic as demon-
strated by Hyakuna et al. [35]. However, these results 
were not consistent with the work of Mitchell et al. [50] 
who reported a mitogenic effect of a mixture of calcium 
phosphate crystals (HA, calcium phosphate, and calcium 
pyrophosphate dihydrate) on synovial cells. Surface 
characteristics and solubility of the materials tested 
could explain this difference. The increase in free cyto-
solic Ca2+ concentration with a simultaneous release of 
inositol(l ,4,5) triphosphate seems to be necessary for a 
mitogenic effect [ 49]. This is consistent with the higher 
mitogenicity of free Ca2+ compared with HA crystals as 
reported by Praeger and Gilchrest [59]. Based on earlier 
reports [36-38] published on the implantation of calcium 
phosphate ceramic, HA-ceramics were supposed to be a 
non- or slowly-degradable material in a biological envi-
ronment. HA was considered as non-resorbable , and 
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{3-TCP was considered as slowly degraded. However, 
the biological effects of the HA on isolated cells related 
to the release of Ca2 + from the ceramic, shows that HA 
is not absolutely stable and may be degraded in living 
tissue. It is particularly interesting to know the factors 
affecting the degradation of HA-coatings which are sup-
posed, in some cases, to last as long as possible, once 
implanted. Klein et al. [39] have demonstrated that the 
solubility of coatings was much higher than sintered par-
ticles. Degradation of calcium phosphate coatings in a 
buffered solution in vitro was shown for tetracalcium 
phosphate , tricalcium phosphate and HA. Maxian et al. 
[47] recently reported that a greater in vitro Ca2+ dis-
solution , and a greater surface, physical, and chemical 
changes were observed for poorly crystallized coatings 
compared to amorphous coatings, suggesting that amor-
phous coatings could be more advantageous if coating 
longevity is desired. This is not consistent with what 
has been previously published [61]. When we investi -
gated the in vitro behaviour of animal cells grown at the 
point of contact of HA-coating having different crystalli-
nities, it was found that more Ca2 + dissolved from coat-
ings having a low crystallinity (40-70%) compared to the 
coating having a high crystallinity (100%) [25]. HA-
particles were found inside cells grown on both poorly 
and highly crystalline coatings . The highly crystalline 
coatings induced a cytostatic effect. It is interesting to 
note that a coating degradation was found in vitro and 
during short periods of time for all the crystallinities 
tested. 
Microscopic evidence of material degradation: 
HA is used under different forms : dense, porous , pow-
dered or thin coatings. Gomi et al. [29] showed that os-
teoclast-like cells resorb sintered synthetic hydroxyapa-
tite in vitro and that the nuclearity of the resorptive cells 
is influenced by the surface topography of the substra-
tum. Koerten et al. [40] demonstrated that spray dried 
HA-spheres were degraded when injected into the mouse 
peritoneal cavity. Miiller-Mai et al. [51] showed the 
microscopic degradation of HA-coating. Recently Basle 
et al. [8) demonstrated that macroporous calcium phos-
phate elicited, at the ceramic contact, the recruitment of 
a double multinucleated cell population, giant multi-
nucleated cells and osteoclasts, having a resorption 
activity. This result is not consistent with that obtained 
by Glowacki et al. [28]; it could be due to the difference 
in features chosen for osteoclast characterization. 
We have been able to perform histological analy-
ses of HA materials implanted in human and animal bone 
in the form of coating or macroporous ceramics in order 
to evaluate the material degradation in vivo. 
Materials and Methods 
Fifteen hip prostheses coated with plasma spray-
ed-HA coatings (characteristics given in Table 1) and 
implanted for periods from 5 days up to three years 
(Table 2) were retrieved post-mortem from patients de-
ceased for reasons which were not directly related to the 
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more than 97% 
Ca 10(P04) 6(0Hh, other com-
pounds admitted: tricalcium 
phosphate (traces), calcium 
oxide (traces), amorphous phase 
60% ± 10% 
150~-tm ± 50~-tm 
As < 3 ppm; Cd < 5 ppm ; 




Table 2. Extreme values of the thickness (in ~-tm) of 
coating implanted for various period (thickness before 
implantation : 100- 150 ~-tm). 
implantation Metaphysis Middle Diaphysis 
12 months 99-220 50- 164 40-184 
24 months 0- 183 0-180 0- 188 
43 months 5 8-164 104-204 119- 163 
1.5 months 104- 143 123-182 164- 119 
7 months 163-137 213-155 






All pores interconnected 
100% HA 
70% 
500- 1500 I-'m 
3~-tm 
hip surgery . The femurs containing the HA-coated pros-
theses were cut into three parts which were fixed into a 
4% formaldehyde solution into PBS (phosphate buffered 
saline). They were dehydrated in alcohol solutions and 
embedded into PMMA (polymethyl methacrylate). Two-
three mm thick sections were made using a low speed 
cooled diamond saw. They were re-embedded at the sur-
face of a polystyrene block and polished until a 50-100 
~-tm thickness. Sections observed using a light micro-
scope were stained with a fuscin-toluidine solution after 
etching the block in a 1% formic acid solution and a 
20% methanol solution . Sections observed using scan-
ning electron microscopy (SEM) were stained with a sil-
ver methenamine solution [23]. Briefly , sections were 
stained using a 1% silver methenamine solution (brought 
to pH 9.6 with NH40H) for 4 minutes in a microwave 
oven at 20% power (2450 MHz). Sections were then ex-
amined using the backscattered mode of a SEM operated 
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at 25 kV. The degradation of the coating was measured 
on sections of 5 HA-coated prostheses using an image 
analysis system. The maximum and minimum coating 
thickness was determined on sections made at three 
levels on each prosthesis. 
On thick sections of two HA-coated prostheses 
implanted three weeks and one year, the prosthesis was 
detached from the bone and treated with a 2% NaOCl 
solution for 24 hours to remove the organic matrix ad-
sorbed on the coating. They were dehydrated and gold-
palladium coated , then they were observed in the SEM 
at 25 kV. 
Twenty macroporous HA ceramics composed of 
pure HA (characteristics given in Table 3) were im-
planted into 9 mm holes drilled into the cortical bone of 
the medium diaphysis of sheep femurs for periods from 
one month up to ten months . Five other ceramics were 
implanted for two months into defects made into the me-
dium diaphysis of dog ' s ulnae . Once retrieved , the im-
plants were processed as described above for histological 
analysis . 
Results and Discussion 
A decrease in the coating thickness was noted 
after a few months of implantation (Table 2). This deg -
radation can appear after a few weeks of implantation 
and was not dependent solely on time . The degradation 
could be completed after a two years implantation period 
or was non-detectable after three years. SEM observa-
tions of specimens , whose organic matter had been re-
moved by NaoCl , showed that the surface of the one 
year implanted coating was very rough (Fig. 3) com-
pared to the surface of the three weeks implanted one 
(Fig. 4). Higher magnifications made it possible to see 
the crystals of the coating suggesting a dissolution of the 
amorphous phase between the grains. Grains also 
showed some degradation marks on some of their facets 
(Fig . 5) . 
Multinucleated cells and mononuclear cells were 
found at the coating contact point in all the sections ex-
amined except the sections taken from the prosthesis im-
planted for five days. These cells were located at the 
coating contact in regions facing medullary cavities. 
Most of them , after a few months implantation period, 
had HA-grains included in their cytoplasm showing a 
phagocytosis of calcium phosphate grains coming from 
the coating (Fig. 6) . Several types of coating degrada-
tion could be described morphologically and were ob-
served both by SEM or light microscopy on prostheses 
coating implanted for a few months (5 months or more). 
Several of these types could be observed on the same 
prosthesis: a) coating having a non-altered thickness in 
contact with multi - or/and mono-nucleated cells contain -
ing HA-particles (Fig . 7); b) coating that was of an al-
tered thickness in regions facing medullary cavities al-
though coating in contact with bone tissue is not altered 
(Fig . 8) ; c) coating having an homogeneously degraded 
thickness; and d) coating degraded regions invaded by 
bone tissue (Fig. 9). 
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Figure 3. Scanning electron micrograph of a one year implanted HA-coated prosthesis in human. The organic phase 
in this sample had been removed by using NaOCl. The coating surface (C) is rough suggesting that degradation 
occurred during the implantation period. Bone trabeculae (B) are apposed on the coating surface. Bar = 550 ~m. 
Figure 4. Scanning electron micrograph of a three weeks implanted HA-coated prosthesis. The organic phase in this 
sample had been removed by using NaOCl. The surface is very smooth showing no degradation sign. Bar = 140 ~m. 
Figure 5. High magnification scanning electron micrograph of the surface of the prosthesis shown in Figure 3. The 
amorphous phase is resorbed and the grains constituting the crystalline phase of the coating are observed. Some of 
these grains show resorption marks on some of their facets (arrowheads). Bar = 10 ~m. 
Figure 6. Back-scattered electron micrograph of a silver methenamine stained section of aHA-coating resorption zone 
(HA) of a two years implanted prosthesis. Osteoclast and macrophages contains calcium-phosphate particles 
(arrowheads). Ti: titanium alloy. Bar = 35 ~m. 
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Cell-Degradation of HA-Ceramics 
Figure 7. Light micrograph of a one year implanted 
HA-coating (HA) which does not show any signs of re-
sorption. Some osteoclasts (solid arrow) are at the 
coating contact and contain HA particles (arrowhead). 
Fuscin-tolu:dine stained section (printed in black and 
white from a color micrograph). Bar = 100 ,urn. 
Figure 8. Back-scattered scanning electron micrograph 
of a silver ethenamine stained section of a one year im-
planted prosthesis showing a decreased coating thickness 
in the region facing a medullary cavity (HA). Some 
cells of the medullary tissue have phagocytosed coating 
debris (arrcwhead) . B: Bone. Bar = 150 J.Lffi. 
Figure 9. Reflected light micrograph of a resorbed 
coating reg1on of a one year implanted prosthesis . Bone 
has grown inside the resorbed coating (arrowheads). B: 
Bone, Ti: 1itanium alloy. Bar = 150 J.Lm . 
Figure lO A. Back-scattered scanning electron micro-
graph of a ;ilver methenamine stained section of a soft 
tissue invaced macroporous HA-ceramic (HA) showing 
resorption 2ones at the implant surface (hollow arrows). 
Cytoplasm Jf mononucleated cells is filled with calcium 
phosphate Erains (arrowheads) identified by energy dis -
persive X-ny spectroscopy . Bar = 40 J.Lm. 
Figure lOE . Same area as in Figure lOA at a higher 
magnificatim . Some cells are filled with calcium phos-
phate grain ; (sol id arrow) . Bar = 10 J.Lm. 
Figure 11 . Back-scattered scanning electron micrograph 
of a silver nethenamine stained section of an HA-ceram-
ic (HA) imJlanted into bone (B) for two months . The 
outside (so id arrow) region of the ceramic facing the 
medullary cavity is less dense suggesting a dissolution of 
the ceramic at the grain boundaries , although macro-
phages at tre ceramic contact contain HA particles. Bar 
60 J.Lm. 
TheS! micrographs showed that HA-coatings were 
degraded W1en implanted into human bones and that the 
degradatio was heterogeneous. HA-particles could be 
released eitter by cell activity: osteoclasts acidifying the 
resorption dlamber at the coating contact or by a dissol-
ution procfSs of the amorphous phase as shown in vitro 
[25]. However , the degradation rate of coatings having 
the same craracteristics was not constant and other fac -
tors such a ~ the cytology of the implanted tissue should 
be taken in o account. 
A ccating remodelling process identical to the 
bone remorelling process described by Frost [26] is sug-
gested by t1e bone ingrowth into coating resorbed re-
gions. The behaviour of bone at the coating contact 
could be in·luenced by protein factors released by coat-
ing degradi1g cells , and by a solution mediated process 
involving tie release of Ca2 + affecting cellular activity 
or mineral >recipitation. 
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A similar process of grain phagocytosis was 
observed on pure HA crystalline ceramics implanted in 
bone defects in dogs invaded by loose connective tissue. 
Mononuclear cells were found at the contact point of the 
ceramic surface. Some of these cells were filled with 
many calcium phosphate grains located inside cell vacu-
oles filling the whole cytoplasm (Fig. 10). They were 
located in close proximity to the ceramic, suggesting that 
the solubilization occurs rapidly inside the vacuoles. No 
morphological sign of cell damage was found. Marks of 
cell resorption were found in the ceramic zones where 
the cells were present. The same HA-ceramics implant-
ed in an osseous site in sheep for periods ranging from 
two months up to ten months and invaded by bone tissue 
seemed both solubilized and cell resorbed (Fig. 11). 
Solubilization took place in the surface region in contact 
with body fluid (in the medullary cavity), and cell re-
sorption took place both in the regions at the bone con-
tact point and in the regions previously partially solubil-
ized. Solubilized regions were identified, on histologi-
cal sections observed using backscattered electron mi-
croscopy as a less dense zone located on the material 
surface surrounding a dense core of ceramic. The de-
crease of density was attributed to resorption occurring 
at the grain boundaries. The evidence of cell resorption 
of these ceramics was found in some regions where the 
structure of the ceramic was altered at the contact of 
some multinucleated cells without HA-grains found in 
their cytopl'asm. This suggested that there was a dis-
solution process before the grain phagocytosis . Al-
though some evidence of cell mediated dissolution exits, 
it is difficult to evaluate from this study , which part of 
the material degradation is due to a solution-mediated 
process and which part is due to a cell-mediated 
dissolution. 
These results were consistent with those published 
by den Hollander et al. [19] who studied the degradation 
of 45Ca-labelled macroporous HA-ceramics. HA showed 
a small decrease in the specific activity of the implant 
suggesting a degradation of the material once implanted. 
However , the lack of radioactivity in the adjacent bone 
normally being an area of increased calcium metabolism, 
indicated the restricted availability of the liberated 45Ca 
for neogenesis of bone tissue. The presence of particles 
of high specific activity was noted in lymph nodes. 
Thus , even HA-ceramics which do not contain an 
amorphous phase are cell degraded both in vivo and in 
vitro. HA-macroporous ceramics used in our observa-
tions had a very low microporosity ( < 2%) with very 
small pores and could be considered as dense material at 
the cell level. The molecular mechanism of HA-degra-
dation once implanted can involve surface processes con-
trolling the dissolution rate of HA-crystal and cell excre-
tion of ions, enzymes and proteins modifying the crystal 
environment. Although the molecular mechanisms rul-
ing the mononuclear precursors of osteoclasts are not 
known, they are influenced by some of the HA-ceramic 
characteristic and could be indirectly involved in the HA 
degradation process. 
P. Frayssinet et al. 
Conclusions 
Dissolution and cell degradation of synthetic HA-
ceramic occur simultaneously and it is very difficult to 
distinguish between them in vivo. We could not estab-
lish a rate of degradation of these ceramics since their 
degradation is a very heterogeneous phenomenon. On 
HA-coatings, the rate of degradation could vary on the 
same prosthesis depending on the location where the 
section was made. Also, depending on the tissue (e.g. , 
bone or bone marrow) in contact with the ceramic coat-
ing, the thickness of the coating facing these tissues is 
not the same. Moreover, the resorption varies from one 
patient to another. 
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